Implantables & Injectables

Our client engaged Health Advances to perform a rigorous assessment of the US lumbar fusion interbody market and a revenue forecast for the client's novel expandable interbody device to both guide its ongoing investments and development roadmap, as well as to share with potential future partners. The team interviewed spine surgeons and spine sales representatives to understand market trends and to gather feedback on the novel device. In addition to physician interviews, the assessment encompassed analyses of procedure volumes, procedure reimbursement, and a detailed competitive landscape of marketed interbody devices. The work also included a survey of 100 spine surgeons to ensure a more robust forecast of future adoption of the novel device within key patient segments. Ultimately, the research culminated in a revenue forecast model for the novel interbody, which included segmentation by surgical approach and scenarios based on potential features of the device.

A neurostimulation company was preparing to launch their device as a 2nd entrant in the US where the incumbent has an 8-year first-mover advantage and substantial commercial investment and footprint. Our client sought a fact-based commercialization strategy and launch plan that considered investments and resources needed to effectively compete with the incumbent and gain share quickly. Health Advances developed a fact base regarding commercialization of the incumbent, conducted interviews with over two dozen physician users, pressure-tested the product's market access readiness and analyzed other second-to-market neurostimulation analogs. These research activities were used to inform a 7-year revenue forecast and prioritize areas of investment for the client. Ultimately, the team developed a launch plan including size and timing of investments in a salesforce and patient demand generation needed to efficiently realize the revenue opportunity.

A client engaged Health Advances to evaluate the outlook for two device companies in the coronary and peripheral intervention device market. Health Advances conducted extensive secondary research and 30 interviews with physicians, purchasing experts, and industry experts in the US and China to inform the competitive positioning and assess the revenue forecasts for both manufacturers. The team also conducted an analysis to evaluate potential commercial synergies for combining the two manufacturers. The research ultimately allowed our client to determine whether to move forward with investments in the market.